Sema4 Holdings Corp. SMFR
We take great care to ensure that the data presented and summarized in this overview for Sema4 Holdings Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SMFR
Top Purchases
Top Sells
About SMFR
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.
Insider Transactions at SMFR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 09
2025
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,220
-65.18%
|
$299,460
$93.0 P/Share
|
|
Jul 09
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,278
-60.88%
|
$490,854
$93.0 P/Share
|
|
Jul 09
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,245
+12.56%
|
$39,840
$32.67 P/Share
|
|
Jul 01
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,344
-7.92%
|
$122,304
$91.37 P/Share
|
|
Jul 01
2025
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,657
-27.98%
|
$878,787
$91.56 P/Share
|
|
Jun 18
2025
|
Keith A. Meister |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+39.1%
|
-
|
|
Jun 18
2025
|
Eli Casdin |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+38.65%
|
-
|
|
Jun 18
2025
|
Richard C Pfenniger Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+23.74%
|
-
|
|
Jun 18
2025
|
Emily M. Leproust |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+37.79%
|
-
|
|
Jun 18
2025
|
Jason Ryan |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+49.75%
|
-
|
|
Jun 18
2025
|
Joshua Ruch |
BUY
Exercise of conversion of derivative security
|
Direct |
12,924
+30.3%
|
-
|
|
Jun 16
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,729
-29.84%
|
$238,656
$64.77 P/Share
|
|
Jun 16
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Exercise of conversion of derivative security
|
Direct |
7,197
-36.54%
|
-
|
|
Jun 16
2025
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,501
-41.84%
|
$672,064
$64.77 P/Share
|
|
Jun 16
2025
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+42.76%
|
-
|
|
Jun 09
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,266
-19.28%
|
$91,152
$72.55 P/Share
|
|
Jun 09
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,462
+27.27%
|
-
|
|
Jun 09
2025
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,639
-36.44%
|
$262,008
$72.55 P/Share
|
|
Jun 09
2025
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,547
+39.6%
|
-
|
|
Jun 02
2025
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
370
-8.27%
|
$26,270
$71.26 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 435K shares |
|---|---|
| Exercise of conversion of derivative security | 344K shares |
| Open market or private purchase | 150K shares |
| Other acquisition or disposition | 414K shares |
| Exercise of conversion of derivative security | 14.4K shares |
|---|---|
| Open market or private sale | 2.14M shares |
| Bona fide gift | 141K shares |